Five things for pharma marketers to know: Tuesday, May 21, 2019
Memory supplements under scrutiny; Gottlieb on pharma advances and income inequality; Grey launches health and wellness practice.
Roundup
Five things for pharma marketers to know: Monday, May 20, 2019
COO departs Amazon-JPM-Berkshire healthcare venture; City considers tobacco-sales ban; Truvada’s high price blamed for stalling HIV-prevention efforts.
Five things for pharma marketers to know: Friday, May 17, 2019
Five more states sue Purdue; Met to no longer take donations from Sacklers; Nestle plans sale of skincare line.
Five things for pharma marketers to know: Thursday, May 16, 2019
North Carolina sues Juul; J&J plans 10 drug launches by 2023; Novartis could settle kickback suit.
Five things for pharma marketers to know: Wednesday, May 15, 2019
Bayer ordered to pay $2 billion in Roundup lawsuit; Scientists predict next cities to be hit with measles outbreak; AbbVie settles Humira patent lawsuit with Boehringer Ingelheim.
Five things for pharma marketers to know: Tuesday, May 14, 2019
Teva, Mylan shares pulled down by anti-trust lawsuit; Insys hints it may file for Chapter 11; U.S. measles cases pass 800 mark.
Five things for pharma marketers to know: Monday, May 13, 2019
Gilead to donate Truvada; Lilly migraine drug pulls ahead of rivals; Washington State ends personal, philosophical exemptions to vaccination.
Five things for pharma marketers to know: Friday, May 10, 2019
Juul campaign draws criticism; Novartis buys dry-eye drug Xiidra; The five companies with the most at stake by putting list prices in TV ads.
Five things for pharma marketers to know: Thursday, May 9, 2019
MM&M’s Transforming Healthcare conference; Trump administration moves forward with drug-price-in-advertising requirement; Walmart raises minimum age to buy tobacco.
Five things for pharma marketers to know: Wednesday, May 8, 2019
More than 75% say kids should be vaccinated even over a parent’s objection; CBD drug Epidiolex beats expectations; Allergan CEO plans “decisive action” in company turnaround.
Five things for pharma marketers to know: Tuesday, May 7, 2019
CDC said New York is driving most new measles cases; FDA approves drug for rare heart condition; Lundbeck buys CBD-focused pharma company.
Five things for pharma marketers to know: Monday, May 6, 2019
Weight Watchers misses on Q1 revenue; Pharma lobbying spend reaches 10-year high; First U.S. CRISPR clinical trial seeks approval.
Five things for pharma marketers to know: Friday, May 3, 2019
Jury finds Insys execs guilty in opioid kickback trial; Attorneys argue federal opioid data should be public; More than half of Americans struggle because of medical bills.
Five things for pharma marketers to know: Thursday, May 2, 2019
Humana CEO won’t back “Medicare for all”; FDA rejects Heron non-opioid painkiller; GSK predicts shingles vaccine will top $1.3b in sales this year.
Five things for pharma marketers to know: Wednesday, May 1, 2019
See MM&M’s Top 40 Healthcare Transformers and Top 10 Innovation Catalysts; Voting begins in the #ConvinceMeToVax contest; Rich Levy joins Klick.
Want to read more?
Please login or register first to view this content.
